VEGF and anti-VEGF in Eye Disease
During this live webinar, Dr. Kazlauskas discusses how anti-VEGF agents provide benefit by temporarily reducing the level of VEGF and overcoming vascular permeability as well as the variable patient response to VEGF. Lecturer: Dr. Andrius Kazlauskas, University of Illinois Eye & Ear Infirmary, Chicago, USA
▶︎
How to Interpret OCT in AMD
▶︎
🫀 2025 BLS Practice Test | CPR & AED Practice Test with Detailed Answers
▶︎
Classification of Diabetic Retinopathy
▶︎
STOP Diabetic Retinopathy: Skills Training in Ophthalmic Photocoagulation
▶︎
Anti-VEGF (ARVO)
▶︎
2. Beyond VEGF: Role of Ang-2 in Retinal Vascular Pathology
▶︎
The Man Who Worked At Subway, Then Solved An "Impossible" Problem
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Lecture: Gene Therapy for AMD: Are We There Yet?
▶︎
Macular OCT Interpretation: A Practical Discussion with Dr. David E. Lederer
▶︎
Lecture: Classification and Management of Diabetic Retinopathy
▶︎
New Option for Anti-VEGF Treatment for Wet Age-Related Macular Degeneration
▶︎
POSTERIOR VITREOUS DETACHMENT and the treatment of vitreous floaters.
▶︎
Case Presentation - CRVO with Macular Edema
▶︎
Mastering OCT Interpretation with Dr. Mark Friedberg
▶︎
Think Fast, Talk Smart: Communication Techniques
▶︎
Anti-VEGF Eye Injections - Why ? For which patients ? Cost ? Risks ? | Dr. Shrutika Kankariya
▶︎
Red Light Therapy: AMD, Fighter Pilots, and More - Dr. Graham Merry, Founder of Arunalight
▶︎
Diabetic Retina Disease - Update 2017: Dr. Wai-Ching Lam & Dr. Peng Yan
▶︎